Literature DB >> 35881792

Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.

Karla T Falcon1, Kristin E N Watt1, Soma Dash1, Ruonan Zhao1,2, Daisuke Sakai1,3, Emma L Moore1, Sharien Fitriasari1, Melissa Childers1, Mihaela E Sardiu1,4, Selene Swanson1, Dai Tsuchiya1, Jay Unruh1, George Bugarinovic1,5, Lin Li6, Rita Shiang6, Annita Achilleos1,7, Jill Dixon8, Michael J Dixon8, Paul A Trainor1,2.   

Abstract

Ribosomal RNA (rRNA) transcription by RNA polymerase I (Pol I) is a critical rate-limiting step in ribosome biogenesis, which is essential for cell survival. Despite its global function, disruptions in ribosome biogenesis cause tissue-specific birth defects called ribosomopathies, which frequently affect craniofacial development. Here, we describe a cellular and molecular mechanism underlying the susceptibility of craniofacial development to disruptions in Pol I transcription. We show that Pol I subunits are highly expressed in the neuroepithelium and neural crest cells (NCCs), which generate most of the craniofacial skeleton. High expression of Pol I subunits sustains elevated rRNA transcription in NCC progenitors, which supports their high tissue-specific levels of protein translation, but also makes NCCs particularly sensitive to rRNA synthesis defects. Consistent with this model, NCC-specific deletion of Pol I subunits Polr1a, Polr1c, and associated factor Tcof1 in mice cell-autonomously diminishes rRNA synthesis, which leads to p53 protein accumulation, resulting in NCC apoptosis and craniofacial anomalies. Furthermore, compound mutations in Pol I subunits and associated factors specifically exacerbate the craniofacial anomalies characteristic of the ribosomopathies Treacher Collins syndrome and Acrofacial Dysostosis-Cincinnati type. Mechanistically, we demonstrate that diminished rRNA synthesis causes an imbalance between rRNA and ribosomal proteins. This leads to increased binding of ribosomal proteins Rpl5 and Rpl11 to Mdm2 and concomitantly diminished binding between Mdm2 and p53. Altogether, our results demonstrate a dynamic spatiotemporal requirement for rRNA transcription during mammalian cranial NCC development and corresponding tissue-specific threshold sensitivities to disruptions in rRNA transcription in the pathogenesis of congenital craniofacial disorders.

Entities:  

Keywords:  Mdm2-p53; RNA polymerase 1; neural crest cells; rRNA transcription; ribosome biogenesis

Mesh:

Substances:

Year:  2022        PMID: 35881792      PMCID: PMC9351356          DOI: 10.1073/pnas.2116974119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  74 in total

1.  Proteomic analysis by multidimensional protein identification technology.

Authors:  Laurence Florens; Michael P Washburn
Journal:  Methods Mol Biol       Date:  2006

2.  FGFR2 mutations in bent bone dysplasia syndrome activate nucleolar stress and perturb cell fate determination.

Authors:  Cynthia L Neben; Creighton T Tuzon; Xiaojing Mao; Fides D Lay; Amy E Merrill
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

3.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

Review 4.  Ribosomopathies: There's strength in numbers.

Authors:  Eric W Mills; Rachel Green
Journal:  Science       Date:  2017-11-03       Impact factor: 47.728

Review 5.  RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance.

Authors:  Yong Liu; Chad Deisenroth; Yanping Zhang
Journal:  Trends Cancer       Date:  2016-04-04

6.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Authors:  P G Komarov; E A Komarova; R V Kondratov; K Christov-Tselkov; J S Coon; M V Chernov; A V Gudkov
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

7.  Preparation, culture, and immortalization of mouse embryonic fibroblasts.

Authors:  Jianming Xu
Journal:  Curr Protoc Mol Biol       Date:  2005-05

Review 8.  Ribosomopathies: Global process, tissue specific defects.

Authors:  Pamela C Yelick; Paul A Trainor
Journal:  Rare Dis       Date:  2015-04-01

9.  Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III.

Authors:  Isabelle Thiffault; Nicole I Wolf; Diane Forget; Kether Guerrero; Luan T Tran; Karine Choquet; Mathieu Lavallée-Adam; Christian Poitras; Bernard Brais; Grace Yoon; Laszlo Sztriha; Richard I Webster; Dagmar Timmann; Bart P van de Warrenburg; Jürgen Seeger; Alíz Zimmermann; Adrienn Máté; Cyril Goizet; Eva Fung; Marjo S van der Knaap; Sébastien Fribourg; Adeline Vanderver; Cas Simons; Ryan J Taft; John R Yates; Benoit Coulombe; Geneviève Bernard
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

10.  The Regulation of rRNA Gene Transcription during Directed Differentiation of Human Embryonic Stem Cells.

Authors:  Jessica L Woolnough; Blake L Atwood; Zhong Liu; Rui Zhao; Keith E Giles
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

View more
  2 in total

1.  Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.

Authors:  Karla T Falcon; Kristin E N Watt; Soma Dash; Ruonan Zhao; Daisuke Sakai; Emma L Moore; Sharien Fitriasari; Melissa Childers; Mihaela E Sardiu; Selene Swanson; Dai Tsuchiya; Jay Unruh; George Bugarinovic; Lin Li; Rita Shiang; Annita Achilleos; Jill Dixon; Michael J Dixon; Paul A Trainor
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-26       Impact factor: 12.779

Review 2.  RNA Polymerases I and III in development and disease.

Authors:  Kristin En Watt; Julia Macintosh; Geneviève Bernard; Paul A Trainor
Journal:  Semin Cell Dev Biol       Date:  2022-04-11       Impact factor: 7.499

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.